论文部分内容阅读
Gemcitabine is a therapeutic agent for advanced breast cancer with high antitumor activity and relatively mild toxicity.Several clinical trials revealed that estrogen receptor (ER) status had relevance to the response of mammary malignancy to chemotherapy.